Literature DB >> 2775637

Cervical wound hematoma after carotid endarterectomy.

R E Welling1, H S Ramadas, K J Gansmuller.   

Abstract

Between 1974 and 1984, 1222 patients underwent carotid endarterectomy at a large community teaching hospital. Twenty-three (1.9%) of these patients required reexploration for hematoma at the endarterectomy site. We reviewed the records of these 23 patients with regard to the incidence of perioperative hypertension; the use of platelet-altering medication, heparin, protamine sulfate, and low molecular weight dextran; and the findings at reoperation. We also reviewed the records of 122 randomly selected patients who did not develop wound hematoma after carotid endarterectomy. The incidence of intraoperative and postoperative hypertension was significantly higher in the hematoma group than in the control group. The incidence of preoperative hypertension was not significantly different between the two groups. More hematoma patients received preoperative platelet-altering medication (43% versus 25%), and fewer received intraoperative protamine sulfate to reverse the effects of heparin (48% versus 66%), but these differences were not significant. This study emphasizes the importance of careful hemodynamic monitoring during and immediately after carotid endarterectomy.

Entities:  

Mesh:

Year:  1989        PMID: 2775637     DOI: 10.1016/S0890-5096(07)60029-6

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  3 in total

1.  Risk of wound hematoma at carotid endarterectomy under dual antiplatelet therapy.

Authors:  Andreas Oldag; Stephan Schreiber; Stefanie Schreiber; Hans-Jochen Heinze; Frank Meyer; Mathias Weber; Zuhir Halloul; Michael Goertler
Journal:  Langenbecks Arch Surg       Date:  2012-06-08       Impact factor: 3.445

2.  Safety and efficacy of fixed-dose heparin in carotid endarterectomy.

Authors:  A Poisik; E J Heyer; R A Solomon; D O Quest; D C Adams; C M Baldasserini; D J McMahon; J Huang; L J Kim; T F Choudhri; E S Connolly
Journal:  Neurosurgery       Date:  1999-09       Impact factor: 4.654

3.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

Authors:  Daniel M Witt; Robby Nieuwlaat; Nathan P Clark; Jack Ansell; Anne Holbrook; Jane Skov; Nadine Shehab; Juliet Mock; Tarra Myers; Francesco Dentali; Mark A Crowther; Arnav Agarwal; Meha Bhatt; Rasha Khatib; John J Riva; Yuan Zhang; Gordon Guyatt
Journal:  Blood Adv       Date:  2018-11-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.